Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, ABIVAX Société Anonyme (ABVX.PA) has a market cap of $0.41 billion USD. According to our data, ABIVAX Société Anonyme is ranked No.6351 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.41 B |
-7.54%
|
| Dec 31, 2024 | $0.45 B |
-31.16%
|
| Dec 29, 2023 | $0.65 B |
58.90%
|
| Dec 30, 2022 | $0.41 B |
-78.35%
|
| Dec 31, 2021 | $1.89 B |
-17.01%
|
| Dec 31, 2020 | $2.27 B |
52.55%
|
| Dec 31, 2019 | $1.49 B |
90.46%
|
| Dec 31, 2018 | $0.78 B |
37.20%
|
| Dec 29, 2017 | $0.57 B |
36.98%
|
| Dec 30, 2016 | $0.42 B |
-55.48%
|
| Dec 30, 2015 | $0.93 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
 Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
 Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
 Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
 Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
 Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
 AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
 Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
 Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
 Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
| Market Cap | = | ABVX.PA Stock Price | * | ABVX.PA Shares Outstanding |
| = | $6.46 | * | 63.37 M | |
| = | $0.41 B |